Home Tools
Log in
Cart

cholecystokinin

Cholecystokinin is a peptide hormone of the gastrointestinal system responsible for stimulating the digestion of fat and protein.
Cat. No. Product name CAS No. Purity Chemical Structure
T68016 Spiroglumide 137795-35-8 98%
Spiroglumide, a CCKB-gastrin antagonist that inhibits dose-dependent pentagastrin-induced acid hypersecretion with an ID50 of 20.1 (8.67-46.4) mg / kg, could be ...
T27503L GV-150013X 151386-96-8 98%
GV-150013X is a potent CCKB antiagonist, pKi= 9.02.
T27503 GV150013 167355-22-8 98%
GV150013 is an antagonist of cholecystokinin-2 (CCK2) receptor.
T6735 XL413 hydrochloride 2062200-97-7 98%
XL413 (BMS-863233) hydrochloride is a potent, selective and ATP competitive inhibitor of Cdc7, with an IC 50 of 3.4 nM. XL413 (BMS-863233) hydrochloride also exh...
TQ0062 Nastorazepide 209219-38-5 98%
Nastorazepide (Z-360) is a selective, orally available antagonist of gastrin/cholecystokinin 2 (CCK-2) receptor with potential antineoplastic activity.
T1052 Proglumide 6620-60-6 98%
Proglumide is a cholecystokinin antagonist, which blocks both the CCKA and CCKB subtypes. Proglumide is a drug that exerts an inhibitory effect on gastric secret...
T6206 PHA-767491 845714-00-3 98%
PHA-767491 is a potent ATP-competitive dual Cdc7/CDK9 inhibitor with IC50 of 10 nM and 34 nM, respectively.
T11868 Lorglumide sodium salt 1021868-76-7 98%
Lorglumide sodium salt is an antagonist of cholecystokinin receptors (CCK).
T9343 N-Cbz-DL-tryptophan 13058-16-7 98%
N-Cbz-DL-tryptophan is a cholecystokinin receptor antagonist, abolished the response of the isolated heart to CCK-8.
TP2030L1 Gastrin I (human) acetate TP2030L1 98%
Gastrin I (human) acetate is the endogenous peptide produced in the stomach, and increases gastric acid secretion via cholecystokinin 2 (CCK2) receptor.
T15759 Lintitript 136381-85-6 98%
Lintitript is a selective antagonist of CCK1 with EC50s of 6 nM and 200 nM for CCK1 and CCK2. The Ki value is 0.2 nM for CCK1.
T2312 Loxiglumide 107097-80-3 98%
Loxiglumide is an antagonist of cholecystokinin (CCK-1) receptor.
TP1931L1 [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate TP1931L1 98%
Broad spectrum neuropeptide inverse agonist and antagonist. Potent full inverse agonist for the ghrelin receptor (EC50 = 5.2 nM); diminishes constitutive ghrelin...
T14932 Ceruletide 17650-98-5 98%
Ceruletide is a potent agonist of cholecystokinin receptor and it also is a safe and effective cholecystokinetic agent. It has a direct spasmogenic effect on the...
T15382 GI 181771 305366-98-7 98%
GI 181771 is an agonist of the cholecystokinin 1 receptor. GI 181771 can be used in studies about obesity.
T3352 XL413 1169558-38-6 98%
XL-413 is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity. XL-413 binds to and inhibits the a...
T14932L Ceruletide Ammonium acetate T14932L 98%
Ceruletide Ammonium acetate is a cholecystokinin (CCK) receptor agonist. Ceruletide Ammonium acetate is a safe and effective cholecystokinetic agent and small bo...
T9991 WAY-620645 742116-45-6 98%
WAY-620645 is a CCK antagonist with antitumor and analgesic activities.
T4579 Pentagastrin 5534-95-2 98%
pentagastrin is a synthetic polypeptide that has effects like gastrin when given parenterally, which can cause the secretion and synthesis of salivary proteins.
TP2030 Gastrin I, human 10047-33-3 98%
Gastrin I, human is an endogenous peptide produced in the stomach that increases pepsinogen and acid secretion via the CCK2 receptor in the rat.
Spiroglumide
T68016
Spiroglumide, a CCKB-gastrin antagonist that inhibits dose-dependent pentagastrin-induced acid hypersecretion with an ID50 of 20.1 (8.67-46.4) mg / kg, could be ...
GV-150013X
T27503L
GV-150013X is a potent CCKB antiagonist, pKi= 9.02.
GV150013
T27503
GV150013 is an antagonist of cholecystokinin-2 (CCK2) receptor.
XL413 hydrochloride
T6735
XL413 (BMS-863233) hydrochloride is a potent, selective and ATP competitive inhibitor of Cdc7, with an IC 50 of 3.4 nM. XL413 (BMS-863233) hydrochloride also exh...
Nastorazepide
TQ0062
Nastorazepide (Z-360) is a selective, orally available antagonist of gastrin/cholecystokinin 2 (CCK-2) receptor with potential antineoplastic activity.
Proglumide
T1052
Proglumide is a cholecystokinin antagonist, which blocks both the CCKA and CCKB subtypes. Proglumide is a drug that exerts an inhibitory effect on gastric secret...
PHA-767491
T6206
PHA-767491 is a potent ATP-competitive dual Cdc7/CDK9 inhibitor with IC50 of 10 nM and 34 nM, respectively.
Lorglumide sodium salt
T11868
Lorglumide sodium salt is an antagonist of cholecystokinin receptors (CCK).
N-Cbz-DL-tryptophan
T9343
N-Cbz-DL-tryptophan is a cholecystokinin receptor antagonist, abolished the response of the isolated heart to CCK-8.
Gastrin I (human) acetate
TP2030L1
Gastrin I (human) acetate is the endogenous peptide produced in the stomach, and increases gastric acid secretion via cholecystokinin 2 (CCK2) receptor.
Lintitript
T15759
Lintitript is a selective antagonist of CCK1 with EC50s of 6 nM and 200 nM for CCK1 and CCK2. The Ki value is 0.2 nM for CCK1.
Loxiglumide
T2312
Loxiglumide is an antagonist of cholecystokinin (CCK-1) receptor.
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate
TP1931L1
Broad spectrum neuropeptide inverse agonist and antagonist. Potent full inverse agonist for the ghrelin receptor (EC50 = 5.2 nM); diminishes constitutive ghrelin...
Ceruletide
T14932
Ceruletide is a potent agonist of cholecystokinin receptor and it also is a safe and effective cholecystokinetic agent. It has a direct spasmogenic effect on the...
GI 181771
T15382
GI 181771 is an agonist of the cholecystokinin 1 receptor. GI 181771 can be used in studies about obesity.
XL413
T3352
XL-413 is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity. XL-413 binds to and inhibits the a...
Ceruletide Ammonium acetate
T14932L
Ceruletide Ammonium acetate is a cholecystokinin (CCK) receptor agonist. Ceruletide Ammonium acetate is a safe and effective cholecystokinetic agent and small bo...
WAY-620645
T9991
WAY-620645 is a CCK antagonist with antitumor and analgesic activities.
Pentagastrin
T4579
pentagastrin is a synthetic polypeptide that has effects like gastrin when given parenterally, which can cause the secretion and synthesis of salivary proteins.
Gastrin I, human
TP2030
Gastrin I, human is an endogenous peptide produced in the stomach that increases pepsinogen and acid secretion via the CCK2 receptor in the rat.
1 2